Literature DB >> 21623921

Cardiopulmonary bypass in a patient with classic paroxysmal nocturnal hemoglobinuria during treatment with eculizumab.

Sandra T A van Bijnen, Harry Vermeer, Jo M J Mourisse, Theo de Witte, Henry A van Swieten, Petra Muus.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21623921     DOI： 10.1111/j.1600-0609.2011.01656.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN： 0902-4441            Impact factor:   2.997


× No keyword cloud information.
  4 in total

Review 1.  Eculizumab: a review of its use in paroxysmal nocturnal haemoglobinuria.

Authors:  Kate McKeage
Journal:  Drugs       Date:  2011-12-03       Impact factor: 9.546

2.  Cholecystectomy in a patient with paroxysmal nocturnal haemoglobinuria undergoing ravulizumab maintenance treatment.

Authors:  Mitsuru Moriyama; Yasuo Aota; Masahiro Okabe; Yoshiaki Osaka; Seiichiro Katagiri; Daigo Akahane; Akihiko Gotoh
Journal:  EJHaem       Date:  2021-11-09

3.  Preoperative administration of eculizumab to prevent surgery-triggered hemolysis during cesarean section with paroxysmal nocturnal hemoglobinuria.

Authors:  Dongping Li; Liangcheng Wang; Isao Horiuchi; Shun-Ichi Kimura; Kenro Chikazawa; Azusa Kimura; Shigetane Sasaki; Tomoyuki Kuwata; Kenjiro Takagi
Journal:  Clin Case Rep       Date:  2018-07-25

4.  Positive Impact of Eculizumab Therapy on Surgery for Budd-Chiari Syndrome in a Patient with Paroxysmal Nocturnal Hemoglobinuria and a Long-Term History of Thrombosis.

Authors:  Silvia De-la-Iglesia; Hugo Luzardo; Angelina Lemes; Melissa Torres; Maria Teresa Gómez-Casares; Naylen Cruz; Teresa Molero
Journal:  Hematol Rep       Date:  2016-09-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.